乳腺癌复发的生物标记与作用靶点 

Assay for genetic quirk can provide a wealth of information on patient disease status and prognosis

https://medicalxpress.com/news/2018-03-assay-genetic-quirk-wealth-patient.html

More information:  Jian Yuan Goh et al. Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence, Nature Medicine (2017). DOI: 10.1038/nm.4405

----------------

研究扩大了对多种癌症进行个性化免疫治疗的潜力

Study extends potential for personalized immunotherapy to large variety of cancers

https://medicalxpress.com/news/2018-03-potential-personalized-immunotherapy-large-variety.html

More information:  Sara Bobisse et al, Sensitive and frequent identification of high avidity neo-epitope specific CD8+ T cells in immunotherapy-naive ovarian cancer, Nature Communications (2018).  DOI: 10.1038/s41467-018-03301-0

------------------

研究发现，癌症幸存者比未患癌的人更容易疲劳

Cancer survivors become fatigued more quickly than their peers, study finds

https://www.news-medical.net/news/20180315/Cancer-survivors-become-fatigued-more-quickly-than-their-peers-study-finds.aspx

-------------------

智能软件既可以象病理学家一样诊断前列腺癌

Smart software can diagnose prostate cancer as well as a pathologist

https://medicalxpress.com/news/2018-03-smart-software-prostate-cancer-pathologist.html

--------------------

免疫系统“双重间谍”可能成为癌症斗争的新伙伴

Immune system 'double agent' could be new ally in cancer fight

https://medicalxpress.com/news/2018-03-immune-agent-ally-cancer.html

More information:   R.K. Subbarao Malireddi et al. TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation, The Journal of Experimental Medicine (2018). DOI: 10.1084/jem.20171922

------------------

新研究可能导致更有效的化疗

New research could lead to more effective chemotherapy

https://lofi.medicalxpress.com/news/2018-03-effective-chemotherapy.html